CSOP NASDAQ-100 Index Daily (2x) Leveraged Product (stock code: 7266.HK) to List on the HKEX
HONG KONG--(BUSINESS WIRE)--The CSOP NASDAQ-100 Index Daily (2x) Leveraged Product (stock code: 7266.HK) will be…
6 years ago
China’s Injection Molded Plastics Market Report 2020 with Leading Injection Molded Plastics Producer Profiles – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Injection Molded Plastics Markets in China" report has been added to ResearchAndMarkets.com's offering.…
6 years ago
The InterEMC 2020 in Shenzhen: New Perspective of the Emergency and Safety Technology Development in China
SHENZHEN, China--(BUSINESS WIRE)--Since 2017, the Emergency & Safety Technology Exhibition of the China Hi-Tech Fair…
6 years ago
TUV Rheinland Reminds the Safety of Bamboo Food Contact Products
Must bamboo products be natural? HONG KONG, CHINA - Media OutReach - 14 May 2020 - "Circular economy" has…
6 years ago
The Ajinomoto Group Introduces a Nutrient Profiling System
First Among Food Companies Based in Japan; Nine Companies in Seven Countries Begin Assessing the…
6 years ago
Toshiba Releases MOSFET Gate Driver Switch IPD for Automotive ECUs
TOKYO--(BUSINESS WIRE)--Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has launched “TPD7107F,” a gate driver switch…
6 years ago
Implications of COVID-19 for the Environment and Sustainability
TOKYO--(BUSINESS WIRE)--#COVID19--On Thursday, 14 May 2020, the Institute for Global Environmental Strategies (IGES) released its…
6 years ago
Viet Nam Global Value Chains: Creating More Value Added to Local Economy From Rising Exports Is a Remaining Question to Tackle by the Government, Says ASEAN-Japan Centre
TOKYO--(BUSINESS WIRE)--While Viet Nam — one of the poorest nations in the world in the…
6 years ago
Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
ABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral,…
6 years ago
Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
French regulator, ANSM, as well as Ethics Committee, CPP, have cleared ABX464 for Phase 2b/3…
6 years ago